Meet the 2021 Career Development Award and Postdoctoral Fellowship Grantees
The LRF Clinical Investigator Career Development Award (CDA) and Postdoctoral Fellowship Grant Program support junior faculty members and PhD and advanced clinical fellows pursuing research in lymphoma and chronic lymphocytic leukemia (CLL). The 15 projects awarded from this year’s class of CDA and Postdoctoral Fellowship grantees include early clinical trials of novel therapies and investigations into the biology of Hodgkin lymphoma (HL), T-cell lymphomas and other lymphoma subtypes, racial disparities, and chimeric antigen receptor (CAR) T cell therapy resistance.
Clinical Investigator Career Development Award
Pamela B. Allen, MD
Winship Cancer Institute of Emory University
Research Study: Racial disparities in advanced stage Mycosis Fungoides/Sézary Syndrome
Lymphoma Focus: Mycosis fungoides, Primary cutaneous T-cell lymphoma, primary cutaneous T-cell lymphoma, Sezary syndrome
Read full Researcher Spotlight >
Jamie Flerlage, MD
St. Jude Children’s Research Hospital, Inc.
Research Study: The Evaluation of NLPHL Across the Age Continuum
Lymphoma Focus: Hodgkin Lymphoma Pediatric Lymphoma Adolescent/Young Adult Lymphoma, Nodular lymphocyte-predominant Hodgkin lymphoma
Read full Researcher Spotlight >
Reid Merryman, MD
Dana-Farber Cancer Institute
Research Study: Ipilimumab with or without nivolumab for patients with relapsed/refractory classic Hodgkin lymphoma
Lymphoma Focus: Hodgkin Lymphoma
Read full Researcher Spotlight >
Marco Ruella, MD
Perelman School of Medicine, University of Pennsylvania
Research Study: A Phase I-II Clinical Trial of CD5 Knocked-Out anti-CD5 CAR T-cells for T-cell non-Hodgkin Lymphomas
Lymphoma Focus: T-cell Lymphoma
Read full Researcher Spotlight >
Postdoctoral Fellowship Grants
Elena Battistello, PhD
New York University School of Medicine
Research Study: 3D chromosomal landscapes of human Peripheral T cell Lymphomas
Lymphoma Focus: T-cell Lymphoma
Read full Researcher Spotlight >
Lydie Debaize, PhD
Dana-Farber Cancer Institute
Research Study: Defining vulnerabilities of minimal residual disease in mantle cell lymphomas
Lymphoma Focus: B-cell Lymphoma Aggressive Lymphoma, Mantle cell lymphoma
Read full Researcher Spotlight >
Kathleen Dixon, PhD
University of Minnesota Twin Cities
Research Study: Generation of NK cells expressing an optimized Fc receptor to enhance antibody-targeting of lymphoma
Lymphoma Focus: Non-Hodgkin Lymphoma B-cell Lymphoma Lymphoma, Non-Hodgkin Lymphomas
Read full Researcher Spotlight >
Edmond Ferris, PhD
Norris Cotton Cancer Center
Research Study: Therapeutic targeting of myc interactions in lymphomas
Lymphoma Focus: B-cell Lymphoma, Non-Hodgkin Lymphoma, T-cell lymphomas
Read full Researcher Spotlight >
Rui Guo, MS, PhD
Brigham and Women’s Hospital, Harvard Medical School
Research Study: Exploiting Metabolism to Modulate Epstein-Barr Virus Epigenetic State in Burkitt Lymphoma
Lymphoma Focus: B-cell Lymphoma, Burkitt lymphoma
Read full Researcher Spotlight >
Alexandre Hirayama, MD
Fred Hutchinson Cancer Research Center
Research Study: Factors in the Large B-cell Lymphoma Tumor Microenvironment that Impact Response to CD19 CAR-T Cells
Lymphoma Focus: Non-Hodgkin Lymphoma B-cell Lymphoma, Diffuse large B-cell lymphoma (DLBCL)
Read full Researcher Spotlight >
Hannah Isles, PhD
Weill Cornell Medicine
Research Study: Understanding the role of SPEN in DLBCL
Lymphoma Focus: B-cell Lymphoma Non-Hodgkin Lymphoma, Marginal zone lymphoma, Diffuse large B-cell lymphoma (DLBCL)
Read full Researcher Spotlight >
Richa Kapoor, PhD
University of Pennsylvania
Research Study: The role of ARID1a in T cell lymphomagenesis
Lymphoma Focus: T-cell lymphomas, Primary cutaneous T-cell lymphoma
Read full Researcher Spotlight >
Phil Lange, PhD
Bruce D. Cheson Fellow
The University of North Carolina at Chapel Hill
Research Study: Adenosinergic signaling as a novel target for viral lymphomas
Lymphoma Focus: B-cell Lymphoma, Posttransplant lymphoproliferative disorders (PTLD), Non-Hodgkin Lymphomas, Hodgkin Lymphomas, Burkitt lymphoma
Read full Researcher Spotlight >
Elisa Mandato, PhD
Dana Farber Cancer Institute
Research Study: Targetable Genetic Bases of Immune Evasion in Diffuse Large B-Cell Lymphoma
Lymphoma Focus: B-cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse large B-cell lymphoma (DLBCL)
Read full Researcher Spotlight >
Nicole Prutsch, PhD
Dana Farber Cancer Institute
Research Study: Leveraging Transcriptional and Signaling Dependencies to treat Anaplastic Large Cell Lymphoma
Lymphoma Focus: Aggressive Lymphoma T-cell, Pediatric Lymphoma Adolescent/Young Adult Lymphoma Non-Hodgkin Lymphoma, Anaplastic large-cell lymphoma (ALK+ or -)
Read full Researcher Spotlight >
Impact on Research
The Lymphoma Research Foundation (LRF) is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma. LRF’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.